Spectrum Wealth Advisory Group, LLC Sorrento Therapeutics, Inc. Transaction History

Spectrum Wealth Advisory Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	SELL	$1.51 - $2.88 $860 - $1,641	-570 Reduced 4.92%	11,023 $17,000
Q2 2022 Jul 29, 2022	SELL	$1.24 - $2.33 $620 - $1,165	-500 Reduced 4.13%	11,593 $23,000
Q1 2022 Apr 22, 2022	SELL	$2.0 - $4.9 $3,000 - $7,350	-1,500 Reduced 11.04%	12,093 $28,000
Q4 2021 Feb 10, 2022	SELL	$4.65 - $7.23 $20,925 - $32,535	-4,500 Reduced 24.87%	13,593 $63,000
Q2 2021 Jul 27, 2021	SELL	$6.35 - $10.0 $6,350 - $10,000	-1,000 Reduced 5.24%	18,093 $175,000
Q1 2021 Apr 19, 2021	SELL	$7.03 - $16.51 $21 - $49	-3 Reduced 0.02%	19,093 $158,000
Q4 2020 Jan 19, 2021	SELL	$5.76 - $11.95 $101,352 - $210,272	-17,596 Reduced 47.96%	19,096 $130,000
Q3 2020 Oct 23, 2020	BUY	$6.17 - $18.82 $111,652 - $340,566	18,096 Added 97.31%	36,692 $422,000
Q2 2020 Jul 15, 2020	BUY	$1.73 - $6.76 $32,171 - $125,708	18,596 New	18,596 $117,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Spectrum Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Spectrum Wealth Advisory Group, LLC with notifications on news.